SCHEMBL4374627

SCHEMBL4374627

O=C(O)c1ccc(OCCc2ccc(Cl)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 3/20 0.71
▸ PKM P14618 1/20 0.57
▸ PPARD Q03181 2/20 0.55
▸ PPARA Q07869 2/20 0.55
▸ PPARG P37231 1/20 0.55
▸ TSHR P16473 2/20 0.55
▸ ALOX15 P16050 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.54
▸ PTGDR2 Q9Y5Y4 1/20 0.54
▸ FFAR1 O14842 1/20 0.54
▸ MAOA P21397 1/20 0.53
▸ MAOB P27338 1/20 0.53
▸ MRGPRX4 Q96LA9 1/20 0.52
▸ RXRA P19793 1/20 0.52
▸ RXRB P28702 1/20 0.52
▸ RXRG P48443 1/20 0.52
▸ PLA2G4B P0C869 1/20 0.52
▸ TAAR1 Q96RJ0 1/20 0.52
▸ BCL2 P10415 1/20 0.52
▸ MAPK1 P28482 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1283804 0.86 MAOB (0.72) NR4A2PPARDPPARAPPARGALDH1A1
SCHEMBL14967365 0.85 NR4A2 (0.73) NR4A2PKMTSHRALDH1A1FFAR1
SCHEMBL5390756 0.85 PKM (0.73) NR4A2PKMPPARGTSHRFFAR1
SCHEMBL4327125 0.85 PKM (0.73) NR4A2PKMPPARGTSHRFFAR1
SCHEMBL14967104 0.84 PKM (0.57) NR4A2PKMPPARDPPARATSHR
SCHEMBL1369316 0.83 NR4A2 (1.00) NR4A2MAOAMAOBMRGPRX4RXRA
SCHEMBL4364274 0.83 MAPT (0.66) NR4A2PPARDPPARAPPARGMAOA
SCHEMBL1284312 0.83 KMT2A (0.61) NR4A2PPARDPPARAPPARGALDH1A1
SCHEMBL5751057 0.82 TSHR (0.74) NR4A2TSHRALOX15ALDH1A1MRGPRX4
SCHEMBL833266 0.82 NPC1 (0.55) NR4A2PPARDPPARAPPARGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1908466-B1 SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME DAIICHI SANKYO CO LTD (JP) 2014-02-19 — — EP disclosed
US-8344029-B2 Substituted propanamide derivative and pharmaceutical composition containing the same DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-01-01 — — US disclosed
US-20090292024-A1 SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-26 — — US disclosed
EP-1908466-A1 SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Daiichi Sankyo Company, Limited (JP) 2008-04-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090292024-A1 SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME PTMS, C1S, ACP3 NR4A2 3812/4885PKM 643/4885PPARD 786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback